ArticleScientific reports2025

Design and biological evaluation of mesalamine-NSAID hybrids targeting the NLRP3 inflammasome: a multi-target strategy for ulcerative colitis therapy.

Misagh Yahya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.